Geoffrey Boner
Overview
Explore the profile of Geoffrey Boner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sumaili E, Shemer R, Kruzel-Davila E, Cohen E, Mutantu P, Bukabau J, et al.
Clin Kidney J
. 2019 Apr;
12(2):188-195.
PMID: 30976395
Background: Sub-Saharan Africans exhibit a higher frequency of chronic kidney disease (CKD) than other populations. In this study, we sought to determine the frequency of apolipoprotein L1 () genotypes in...
2.
Wasser W, Boner G, Koslowsky M, Lazar A
BMC Nephrol
. 2018 Jun;
19(1):128.
PMID: 29879921
Background: The 2014 Consensus Conference on Best Practices in Living Kidney Donations recognized live donor kidney transplantation as the best treatment for late-stage kidney disease, yielding superior graft and patient...
3.
Boner G
Diabetes Metab Res Rev
. 2011 Mar;
27(5):425-9.
PMID: 21432982
Diabetes mellitus and its complications are major causes of morbidity and mortality. Traditionally hypertension and poor diabetic control have been considered to be major risk factors for the development of...
4.
Weiss-Salz I, Mandel M, Galai N, Boner G, Mor E, Nakache R, et al.
Clin Transplant
. 2005 May;
19(3):372-6.
PMID: 15877801
The effect of 'old-to-old' cadaveric renal transplants on operative complications and graft survival was assessed in all 325 patients undergoing solitary cadaveric renal transplantations in Israel during a 3-yr period....
5.
Rizkalla B, Forbes J, Cao Z, Boner G, Cooper M
J Hypertens
. 2005 Jan;
23(1):153-64.
PMID: 15643138
Objective: It has been postulated that vascular endothelial growth factor (VEGF) plays a role in the progression of renal injury. However, the role of other angiogenic factors and their receptors,...
6.
Agmon D, Zohar M, Boner G
Am J Kidney Dis
. 2004 Nov;
44(6):A45, e91-2.
PMID: 15558510
No abstract available.
7.
Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk D
J Renin Angiotensin Aldosterone Syst
. 2004 Nov;
5(3):146-51.
PMID: 15526251
Introduction: Combination therapy with angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) is used to improve renal outcome achieved by monotherapy in diabetic patients. In addition, interference with the...
8.
Thallas-Bonke V, Lindschau C, Rizkalla B, Bach L, Boner G, Meier M, et al.
Diabetes
. 2004 Oct;
53(11):2921-30.
PMID: 15504973
This study investigated the role of advanced glycation end products (AGEs) in mediating protein kinase C (PKC) isoform expression in diabetic nephropathy. In vitro, vascular smooth muscle cells incubated in...
9.
Weiss-Salz I, Mandel M, Galai N, Nave I, Boner G, Mor E, et al.
Clin Transplant
. 2004 Sep;
18(5):571-5.
PMID: 15344962
The risk profile for primary renal graft failure is largely unknown because of its inclusion with secondary failures or its exclusion from analysis. This study compares characteristics of the cadaveric...
10.
Zucker I, Yosipovitch G, David M, Gafter U, Boner G
J Am Acad Dermatol
. 2003 Oct;
49(5):842-6.
PMID: 14576662
Background: Pruritus is a common disabling problem in patients with advanced end-stage renal disease. Few studies have evaluated the clinical characteristics of uremic itch. Objectives: The aim of this multicenter...